Analysts Stocks

      UBS Upgrades CYTK to Buy, PT $115

      UBS analyst Ashwani Verma bumped up their price target on CYTK to $115 on June 29, upgrading the rating to Buy from Neutral.

      AnaChart has tracked 14 price-target calls from Ashwani on CYTK. The stock’s price reached the target in 12 of 14 of those calls.

      CYTK carries 15 Buy, 2 Hold ratings among the analysts AnaChart tracks. Price targets run from Jason Zemansky‘s $56 at BAML to Joseph Pantginis‘s $140 at HC Wainwright. The stock’s most recent close was $86.07.

      CYTK price target chart: UBS raises to $115
      Ashwani Verma’s CYTK target history against the street high, street low and the stock price. Each dot marks a dated call.

      The $115 target is 34% above the stock’s $86.07 close.

      FAQ

      What is UBS’s price target on CYTK?

      UBS’s Ashwani Verma has a $115 target on CYTK, rated Buy, set June 29, 2026.

      How often have Ashwani Verma’s CYTK price targets been reached?

      AnaChart has tracked 14 price-target calls from Ashwani Verma on CYTK; the stock reached the target in 12 of them (86%).

      What is the analyst view on CYTK?

      Coverage is split 15 Buy / 2 Hold / 0 Sell, with targets from $56 (BAML) to $140 (HC Wainwright).